Is the US drug-pricing system broken? Is there a way to lower drug prices while minimizing the impact of those changes on the invention of new drugs? What insights we can get under the Covid-19 pandemic? Join us for a panel discussion with a group of experts working in the healthcare industry or doing research on drug pricing regulation.
Dr. Jessica Sagers, RA Capital
Prof. Rena Conti, BU
Dr. Ekaterina Cleary, Bentley
You will learn the current drug pricing situation in the US from both biopharma and policymaker perspectives, what impact drug pricing reform would have on the healthcare industry, and what young scientists who are entering the industry can contribute to solving the problems.
Please RSVP here to receive the Zoom invite, even if you previously registered for our in-person event.
We apologize for the inconvenience and appreciate your understanding.
The event will be a 60 min. panel discussion followed by 30 min. Q&A.
We happily request that you submit questions during registration.
We will also field questions submitted during the event.
You will be able to submit and rank questions in a browser-based tool, and the panelists will answer the top-rated ones.